Role of initial near total (95%) pancreatectomy in persistent neonatal hyperinsulinism (PNH)

M J Haddad1, P M Mathew

  • 1Surgical Services Division, Saudi Aramco Medical Services Organization, Saudi Aramco-Dhahran Health Center, Saudi Arabia.

Insights

Ninety-five percent pancreatectomy is the best initial procedure for persistent neonatal hyperinsulinism (PNH), offering the best prognosis. Recurrent hypoglycemia after this surgery can be medically managed.

Area of Science:

  • Pediatric Surgery
  • Endocrinology
  • Neonatology

Background:

  • Persistent neonatal hyperinsulinism (PNH) is a rare cause of persistent hypoglycemia in newborns.
  • Surgical management, particularly pancreatectomy, is often required for severe cases unresponsive to medical therapy.

Purpose of the Study:

  • To evaluate the long-term outcomes of surgical management for PNH.
  • To determine the optimal extent of pancreatectomy for PNH.
  • To assess the recurrence rates and management of hypoglycemia post-pancreatectomy.

Main Methods:

  • Retrospective analysis of 14 infants with PNH who underwent surgery between July 1983 and June 1992.
  • Review of surgical extent (85% or 95% pancreatectomy) and long-term follow-up data.
  • Analysis of outcomes including normoglycemia, diabetes, and recurrent hypoglycemia.

Main Results:

  • Twelve patients achieved normoglycemia and discontinued medication after initial pancreatectomy (11 with 95%, 1 with 85%).
  • One patient required re-operation after 95% pancreatectomy due to recurrent hypoglycemia, developing diabetes.
  • Three patients experienced recurrent hypoglycemia post-95% pancreatectomy; two were managed with diazoxide, and one with carnitine therapy for associated carnitine deficiency.

Conclusions:

  • Ninety-five percent pancreatectomy as an initial surgical approach offers the best prognosis for PNH.
  • Recurrence of hypoglycemia following 95% pancreatectomy can occur but is often manageable with medical treatment.

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...